Sort
51,570 grants matching “autoimmune disease”
IMMUNOGENETIC MECHANISMS OF EXPERIMENTAL CROHN'S DISEASE
$990,850University Of Virginia Charlottesville · P01 · FY2001 · DK
Sphingolipid Signaling in Mammals
$990,585Jairaj Acharya · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Colorado AMC REACH Hub
$990,415Richard C Duke · University Of Colorado Denver · U01 · FY2021 · HL
IEDB for Multiple sclerosis, Rheumatoid Arthritis, Lupus, and Type 1 Diabetes
$990,248Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2014 · AI
Mechanisms Of Activation Of NF-kappaB, A Mediator Of The Immune Response
$990,237Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Advancing an accessible, high-throughput and multiplex islet autoantibody test with self-collected capillary dried blood spots for regulatory clearance
$990,010David Seftel · Enable Biosciences, Inc. · R44 · FY2023 · DK
Nuclear receptors: action, functions, and roles in disease
$989,992Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Development of a Novel MRI Contrast Agent for Early Detection of Alcoholic Steatohepatitis
$989,930Jenny J Yang · Inlighta Biosciences, Llc · UT2 · FY2020 · AA
Malaria Transmission Blocking Vaccine Discovery
$989,562Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Nutritional Primary Prevention of Type 1 Diabetes
$989,523Dorothy J Becker · Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2006 · HD
A polymeric biomaterial-based vaccine utilizing immunomodulatory agents and antigen for the amelioration of type 1 diabetes.
$989,307Benjamin Michael Looney · Onevax, Llc · R44 · FY2020 · DK
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2
$989,284Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2024 · CA
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$989,186Chetan Seshadri · University Of Washington · R01 · FY2025 · AI
Novel immunotherapy against MOG antibody disease
$988,943Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2025 · TR
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
$988,840Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2021 · AI
Studies Of Hereditary Neurological Disease: Disease Gene Identification
$988,642Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Clinical Core
$988,066Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · U19 · FY2024 · AI
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
$987,225Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · AG
Control of Autoimmunity by Regulatory T Cells
$987,209Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Genetic and Pathophysiologic Study of Atopic Disease
$986,512Joshua Milner · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$985,870Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Colorado AMC REACH Hub
$985,828Richard C Duke · University Of Colorado Denver · U01 · FY2022 · HL
Host Immunity Against Bacteria
$985,803Ian Myles · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGENS
$985,786Timothy A Springer · Immune Disease Institute, Inc. · R37 · FY2009 · CA
IMMUNOGENETICS OF DEMYELINATION
$985,119Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2001 · NS